NYXH
USDNyxoah SA Ordinary Shares
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$6.020
Kõrge
$6.200
Madal
$6.012
Maht
0.01M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
230.2M
Tööstusharu
Medical Instruments & Supplies
Riik
Belgium
Kauplemisstatistika
Keskmine maht
0.14M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...
Stifel Maintains Buy on Nyxoah, Lowers Price Target to $14
Stifel analyst Jonathan Block maintains Nyxoah with a Buy and lowers the price target from $15 to $14.
Conditional Issuance of Shares
INSIDE INFORMATIONREGULATED INFORMATION Conditional Issuance of Shares Mont-Saint-Guibert, Belgium – April 16, 2025, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"),
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...
HC Wainwright & Co. Reiterates Buy on Nyxoah, Maintains $15 Price Target
HC Wainwright & Co. analyst Edward White reiterates Nyxoah with a Buy and maintains $15 price target.
Nyxoah Provides Update on FDA Approvable Letter for Genio System
Nyxoah Provides Update on FDA Approvable Letter for Genio System Expects to meet final FDA requirements for full PMA approval in the second quarter Mont-Saint-Guibert, Belgium – April 8, 2025, 07:00am CET / 1:00am ET –
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.